News
NHS "isn't delivering equitable care for rare diseases"
A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing
Sponsored
Using AI-driven synthetic personas to take your insights fur...
As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
Market Access
12 questions with: Daniel Kohlstaedt
Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry.
Digital
Sponsored
Expert Directed Applied Intelligence: Redefining AI in Life ...
In a new white paper from Lumanity, explore why the most powerful AI will always be human-directed.
Oncology
Sponsored
Collaboration & personalisation in rare disease R&D, with AO...
For Rare Disease Day, in an AOP Health-sponsored podcast Melissa Fellner, VP of Global Therapeutic Areas, Commercial Operations, discussed their work.
Digital
Sponsored
Data managers and CRAs warn of rising data quality risks due...
A new industry report uncovers the scope of a long-ignored problem in clinical trial operations.
R&D
Partner Content
Emerging Trends in Personalised Medicine at PHARMAP 2026
The Pharmaceutical Manufacturing & Packaging Congress is an exclusive annual event that fosters networking and knowledge-sharing among professionals
R&D
Partner Content
5th mRNA-Based Therapeutics Summit Europe
The Summit is the leading European industry-focused forum dedicated to accelerating the development of messenger RNA (mRNA) medicines